<div class="raw-html-embed"><a href="https://libratech.ai/ch/?utm_source=partner&amp;utm_medium=website&amp;utm_campaign=wkch_libra_prsp_staempfli_07_2026
">Stämpfli Fachinhalte - jetzt im rechtssicheren Libra All-In-One AI Workspace verfügbar - Jetzt kostenlos testen!</a></div>

Über uns

À propos de nous

Nachhaltigkeit

Durabilité

Open Access

Karriere

Carrière

Aboverträge Kündigen

Résiliation d’abonnement

Vertrag widerrufen

Résiliation de contrat 

Datenschutz

Protection des données

Impressum

Mentions légales

Zahlung und Lieferung

Paiement et livraison

Libra

Was ist Libra?

C'est quoi Libra ?

Kostenlos testen

Tester gratuitement

LEXIA

LEXIA Arbeitsrecht

Was ist LEXIA?

C'est quoi LEXIA ?

LEXIA Familienrecht

Zeitschriften

Revues

recht

Pflegerecht

ZBJV

forumpoenale

ZStrR

Anwaltsrevue

Revue de l'avocat

RSAS

FamPra.ch

ASYL

Life Science Recht

BlAR

Sachbuch

Livres spécialisés

LOKI

Semaphor

Fokusthemen

Focus

Thema

Recht studieren

Arbeitsrecht

Droit du travail

Studium

Études

Familienrecht

Droit de la famille

Sozialversicherungsrecht

Droit des assurances sociales

Strafrecht

Droit pénal

Aktienrecht

Droit des sociétés anonymes

Publikationen

Publications

Literatur

Digitales Angebot

Bücher

Livres

Buchreihen

Collections

Onlinemodule LEXIA

Modules en ligne LEXIA

recht.ch

Studienliteratur

Littérature pour les études

Dienstleistungen

Services

Dienstleistungen für

Corporate Books

Publishing Lösungen

Aktuelles

Geschäftskunden

Professionnels

Corporate Publishing

Content solutions

Buchhandlungen

Librairies

Veranstaltungen

Événements

Presse

Dozierende

Enseignants

Studierende

Étudiants

Inserierende

Annonceurs

Newsletter

Blog

Autorinnen/Autoren

Auteurs

Unsere Schreibenden

Hilfe

Unsere Autorinnen und Autoren

Liste

Autorenlounge

Espace des auteurs

Bei uns publizieren

Publier chez nous

Autorenstimmen

Témoignages

Verlag

Éditions

Themen

Mehr wissen

Mitarbeitende

Collaborateurs

Geschichte

Histoire

Vision und Mission

Vision et mission

Unser Magazin

Notre magazine

Unternehmenskultur

Culture d'entreprise

Partner

Partenaires

Kontakt

Contact

Shop

Schweizer Recht

Ausländisches Recht

Über unseren Shop

Neuerscheinungen

Nouveautés

Unsere Funktionen

Nos fonctions

Vorankündigungen

À paraître

Nach Rechtsgebiet

Par domaine juridique

Kommentare

Commentaires

Gesamtkatalog

Catalogue complet

Targeting Chronic Inflammatory Lung
Diseases Using Advanced Drug Delivery S

Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems

Artificial intelligence (AI) is fundamentally reshapes the healthcare sector and offers transformational improvements in patient care, to improve operational efficiency, and to do medical research. This paper investigates the integration of AI with Green Human Resource Management (GHRM) practices in hospitals, emphasizing how this synergy can enhance sustainability and environmental performance. Through a comprehensive analysis of secondary data, including recent literature on AI and GHRM, the study explores the potential of AI to advance green practices within healthcare settings. AI's capabilities in analyzing large datasets, improving diagnostic accuracy, and streamlining administrative tasks are examined alongside its role in promot¿ing sustainability.

Research and Innovations in Industrial and Marine Biotechnology: A Circular Economy 2024

“The choice to invest in vaccines rather than in weapons; in treatments for rare diseases rather than in speculative consumer products; in long-term infrastructure rather than in short-term optics—these are not technical decisions. They are moral decisions . . .” Biotech in the Balance by Dr. Jeremy M. Levin shows why the next lifesaving medicines may not arrive on time, and what we can do about that in a period of political change. This is not a technical book. It is a bedside-to-boardroom story, told from inside the system, with a clear map of what has to change so that medicines keep arriving when people need them. When funding for research and development is politicized, trust in science erodes and the foundations of biotechnology weaken. When science is treated as a partisan symbol rather than a shared foundation for health, patients and families bear the consequences. Dr. Levin’s career began as a scientist studying the structure of DNA, and then as a physician in university hospitals in London, Cape Town, and Geneva. As a doctor, he saw the difference between patients saved by medicines that arrived just in time, and those who were not so fortunate. That experience led to a simple conviction: drug discovery and development is not an abstract business. It is a living coalition of scientists, governments, businesses, and—above all—patients. For patients and their families, profitability and internal strategy are not the point. What matters is whether a therapy works, how quickly results can be seen, and how benefits are weighed against risks—including the risk of doing nothing. Throughout the book, Dr. Levin keeps patients at the center of the discussion—politics, markets, supply chains, and governance—and shows how each of these forces can accelerate or delay medical progress. Written from the perspective of a scientist and physician, Biotech in the Balance argues for a resilient, globally competitive biotechnology industry built to serve patients and earn lasting public trust. It offers a call to action for preserving biotechnology as a strategic asset—and a practical framework for leaders who want to strengthen the system rather than merely defend it.

Saving a Strategic Industry in an Age of Distrust

Biotech in the Balance

How living in space will affect future generations—and what the potential unintended consequences of space settlements are. We are on the cusp of a golden age of space travel in which, for the first time, it will be possible for large numbers of people to venture into space. Some intend to stay. But what happens—and will happen—to us in the extreme conditions of space? What should space tourists expect to happen to them during a journey to an orbiting space station, the Moon, or Mars? What would happen to children born on another planet? Would they evolve into a new species? In Becoming Martian, Scott Solomon explores the many ways in which humanity’s migration into space will change our bodies and our minds. This book focuses on the latest science, taking readers to the front lines of research. We hear from astronauts, including Scott Kelly who writes the foreword, and we join a team of scientists guiding a rover across the surface of Mars. We visit a high-security lab where engineers are simulating space radiation to measure its effects on the body. We travel to isolated islands where field biologists are gleaning insights into evolutionary processes applicable to people isolated on faraway planets. We meet synthetic biologists developing gene-editing tools to equip future humans to thrive in alien environments. We watch a rocket designed to carry humanity to Mars make its first successful launch. And then we ask, knowing what we know: Should we go?

How living in space will affect future generations and what the potential unintended consequences of space settlements are.

Our Future Beyond Earth

Becoming Martian

Advanced Biotechnology

Enables researchers and engineers to gain insights into the capabilities of machine learning approaches to power applications in their fields Machine Learning and Big Data-enabled Biotechnology discusses how machine learning and big data can be used in biotechnology for a wide breadth of topics, providing tools essential to support efforts in process control, reactor performance evaluation, and research target identification. Topics explored in Machine Learning and Big Data-enabled Biotechnology include: <ul><li>Deep learning approaches for synthetic biology part design and automated approaches for GSM development from DNA sequences</li> <li>De novo protein structure and design tools, pathway discovery and retrobiosynthesis, enzyme functional classifications, and proteomics machine learning approaches</li> <li>Metabolomics big data approaches, metabolic production, strain engineering, flux design, and use of generative AI and natural language processing for cell models</li> <li>Automated function and learning in biofoundries and strain designs</li> <li>Machine learning predictions of phenotype and bioreactor performance</li></ul> Machine Learning and Big Data-enabled Biotechnology earns a well-deserved spot on the bookshelves of reaction, process, catalytic, and environmental engineers seeking to explore the vast opportunities presented by rapidly developing technologies.

The book discusses how Machine Learning and Big Data is and can be used in biotechnology for a wide breath of topics. It is separated 
 
 into three main parts, with the first covering DNA and ranging from ?synthetic biology part design (such as promoters)? to ?predictions from genome sequences?. The second part concerns proteins, with topics ranging from ?structure and design tools? to ?pathway discovery / retrobiosynthesis?, while the last part covers whole cells and ranges from ?Machine Learning approaches for gene expression? to ?Machine Learning predictions of phenotype and bioreactor performance?

Machine Learning and Big Data-enabled Biotechnology

Nanotechnology-Based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management explores innovative drug delivery systems utilizing nanotechnology to revolutionize the treatment and management of COPD. By presenting the latest advancements in nanotechnologies-including polymeric nanoparticles, liposomes, and theranostic nanoparticles-this volume aims to enhance patient outcomes, alleviate symptoms, and improve lung function, thereby addressing the urgent need for more effective therapies. Structured to cater to a diverse audience, from beginners to advanced researchers, this comprehensive text begins with an overview of COPD, its epidemiology, and current limitations in treatment. The core chapters explore a wide range of nanotechnological applications for diagnosis and disease management, including cutting-edge topics such as nano-immunotherapy and green nanotechnology. Each chapter was developed by a multidisciplinary team of experts from academia and industry, ensuring a comprehensive approach that integrates insights from pharmaceutical sciences, respiratory health, and bioinformatics. Nanotechnology-based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management not only fills a critical gap in COPD literature but also serves as an invaluable resource for researchers, clinicians, and students alike. It promises to be a definitive guide on how innovative drug delivery systems can transform COPD care, paving the way for future advancements in respiratory health management.

Nanotechnology-Based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management

Rethinking Development

We are living in a period of global volatility in which intersecting crises are combining with devastating impacts for people already living in and near poverty. This book carefully examines the dynamics of these crises and challenges us to find new ways forward for policies and programming that more effectively meet the needs of the world's most vulnerable populations.The book highlights lived experiences of those who are impacted most by poverty amidst intersecting crises-namely climate-related disasters, violent conflict and economic instability- drawing on the author's 15 years of experience in sub-Saharan Africa and South and Southeast Asia. It examines chronic poverty amidst intersecting crises, highlighting how new impoverishment may emerge, and even surprisingly how some people manage to escape or remain out of poverty in these contexts. It offers a multi-scalar, dynamic investigation of poverty and intersecting crises to identify ways forward for policies and programming.It is an essential read for practitioners working on poverty and inequality reduction in low- and middle-income countries, as well as for researchers and students of global development, environmental and peace studies, and economics, public policy, and sociology more broadly.

Dynamic Pathways for Lasting Change

Poverty in Polycrisis

Build an Audit-Defensible Corrective and Preventive Action System - Root-Cause Tools, Effectiveness-Check Design, and Closure Records to Survive FDA Inspection Under the QMSR

The Medical Device CAPA Protocol Manual

Leadership in Global Health outlines the essential leadership principles that transform promising health interventions into global movements, offering a timely and compelling blueprint for leaders seeking to drive lasting, scalable change.Grounded in decades of lessons from global health successes and failures, and illustrated through deeply analyzed, real-world case studies, the book reveals what happens when leadership meets coordinated action. These stories- from the eradication of smallpox and the large-scale delivery of malaria bed nets to the community-based innovations of Ethiopia's Health Extension Program and the lightning-fast COVID-19 vaccine rollout-show how leadership in global health is not one-size-fits-all, but rather dynamic, responsive, and deeply human. In an era where complex health challenges range from emerging pandemics to enduring inequities, the book centers the role of leadership-strategic, adaptive, and collaborative-as the critical engine for scaling health interventions, offering readers not only compelling narratives from the field, but also practical tools and reflections which give the book a forward-looking focus.Building to offer a roadmap for developing the next generation of global health leaders equipped to thrive in multi-sectoral, rapidly evolving environments, it will be essential reading for students, scholars and practitioners across Global Health, Public Health, Leadership and Development Studies.

A Strategic Blueprint for Scalable Change

Leadership in Global Health

Wir leben in einer Welt der Daten. Daten allein aber sind wertlos, wenn wir nicht in der Lage sind, aus ihnen Informationen zu gewinnen. Um Informationen aus Daten zu extrahieren, sind Methoden der multivariaten Datenanalyse unerlässlich. Dieses Lehrbuch bietet eine leicht verständliche Einführung in weiterführende Verfahren der multivariaten Datenanalyse, die vor allem in Master- und Doktoranden-Studiengänge häufig verwendet werden. Es ist anwendungsorientiert geschrieben, setzt nur wenige Kenntnisse in Mathematik und Statistik voraus und demonstriert jedes Verfahren mit numerischen Beispielen. Für die vierte Auflage wurden alle Kapitel aktualisiert und um zentrale Entwicklungen ergänzt, die für Einsteiger besonders wichtig sind. Neu aufgenommen wurde die Zeitreihenanalyse. Das vorliegende Buch und das bereits in der 18. Auflage erschienene Buch Multivariate Analysemethoden der Autoren wurden im Jahr 2015 vom Berufsverband Deutscher Markt- und Sozialforscher e. V. (BVM) mit dem Preis der Deutschen Marktforschung ausgezeichnet, da sie die deutsche Marktforschungspraxis in den letzten Jahrzehnten nachhaltig geprägt haben.
Die im Buch behandelten Verfahren und die verwendeten Softwareprogramme: Nichtlineare Regressionsanalyse – Zeitreihenanalyse – Strukturgleichungsanalyse (SGA) – Konfirmatorische Faktorenanalyse (KF) – Choice Based Conjoint Analyse (CBCA) – Künstliche Neuronale Netze – Multidimensionale Skalierung – Korrespondenzanalyse
Wichtige Berechnungen zu den Verfahren werden zunächst mit MS-Excel verdeutlicht und anschließend zu allen Verfahren ausführliche Fallbeispiele mit einschlägigen Software-Programmen gerechnet. Dabei werden die SGA und die KF mit AMOS und die CBCA mit Lighthouse Studio von Sawtooth gerechnet. Bei allen anderen Verfahren wird auf IBM SPSS zurückgegriffen.
Hilfestellungen für den Anwender: Mit der Springer Nature Flashcards-App kann der eigene Lernfortschritt interaktiv kontrolliert und exklusive Inhalte genutzt werden. Die Webseite multivariate.de bietet weitere Informationen zu den Verfahren und eine Bestellmöglichkeit zu den Datensätzen und Syntaxdateien.
Die Autoren

Wir leben in einer Welt der Daten. Daten allein aber sind wertlos, wenn wir nicht in der Lage sind, aus ihnen Informationen zu gewinnen. Um Informationen aus Daten zu extrahieren, sind Methoden der multivariaten Datenanalyse unerlässlich.
 
 Dieses Lehrbuch bietet eine leicht verständliche Einführung in weiterführende Verfahren der multivariaten Datenanalyse, die vor allem in Master- und Doktoranden-Studiengänge häufig verwendet werden. Es ist anwendungsorientiert geschrieben, setzt nur wenige Kenntnisse in Mathematik und Statistik voraus und demonstriert jedes Verfahren mit numerischen Beispielen. Für die vierte Auflage wurden alle Kapitel aktualisiert und um zentrale Entwicklungen ergänzt, die für Einsteiger besonders wichtig sind. Neu aufgenommen wurde die Zeitreihenanalyse.
 
 Das vorliegende Buch und das bereits in der 18. Auflage erschienene Buch 
 Multivariate Analysemethoden
 der Autoren wurden im Jahr 2015 vom Berufsverband Deutscher Markt- und Sozialforscher e. V. (BVM) mit dem Preis der Deutschen Marktforschung ausgezeichnet, da sie die deutsche Marktforschungspraxis in den letzten Jahrzehnten nachhaltig geprägt haben.
 
 Die im Buch behandelten Verfahren und die verwendeten Softwareprogramme:
 
 Nichtlineare Regressionsanalyse – Zeitreihenanalyse – Strukturgleichungsanalyse (SGA) – Konfirmatorische Faktorenanalyse (KF) – Choice Based Conjoint Analyse (CBCA) – Künstliche Neuronale Netze – Multidimensionale Skalierung – Korrespondenzanalyse
 Wichtige Berechnungen zu den Verfahren werden zunächst mit MS-Excel verdeutlicht und anschließend zu allen Verfahren ausführliche Fallbeispiele mit einschlägigen Software-Programmen gerechnet. Dabei werden die SGA und die KF mit AMOS und die CBCA mit Lighthouse Studio von Sawtooth gerechnet. Bei allen anderen Verfahren wird auf IBM SPSS zurückgegriffen.
 Hilfestellungen für den Anwender:
 
 Mit der Springer Nature Flashcards-App kann der eigene Lernfortschritt interaktiv kontrolliert und exklusive Inhalte genutzt werden. Die Webseite multivariate.de bietet weitere Informationen zu den Verfahren und eine Bestellmöglichkeit zu den Datensätzen und Syntaxdateien.

Eine anwendungsorientierte Einführung

Fortgeschrittene Multivariate Analysemethoden

Previously known as Drafting Agreements in the Biotechnology and Pharmaceutical Industries, this title provides precedent agreements for the main types of commercial transaction encountered in the life sciences, biotechnology and pharmaceutical industries. In addition to the print version, each precedent is available via an accompanying website in a format which can be easily downloaded and edited. Detailed commentary on legal, commercial and practice issues accompanies every precedent. Provided by specialist lawyers from across Europe, this commentary also highlights important differences between English law and that of other key EU jurisdictions: Germany, France, the Netherlands, Spain and Sweden. Commentary on specific considerations for the US is also provided. In addition to precedent commentaries, the book also contains detailed commentary and discussion of legal issues common to the life sciences, biotechnology and pharmaceutical industries, as well as links to relevant materials (eg regulatory materials on clinical trials). This title is included in Bloomsbury Professional's Intellectual Property and IT online service.

Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems

Weitere Titel zum Thema